Our people

QCGC Research seeking kinder & gentler treatment options
QCGC Research seeking kinder & gentler treatment options

QCGC

Queensland Centre for Gynaecological Cancer

The Queensland Centre for Gynaecological Cancer (QCGC) is a state-wide service for the management of women with gynaecological cancer (cancer of the ovaries, the uterus, the cervix, the vulva and vagina).

QCGC works in partnership with Queensland Health for the State's gynaecological cancer services. QCGC is lead by a Director and ten gynaecological oncologists providing services to major hospitals in Brisbane, including The Wesley Hospital, Mater Misericordiae and Greenslopes Private Hospital. The team also travels regularly to regional Queensland, particularly Gold Coast, Sunshine Coast, Toowoomba and Darling Downs, Far North Queensland and the Northern Territory.

QCGC Research

Queensland Centre for Gynaecological Cancer Research

QCGC Research is the research branch of QCGC and is an academic (non-profit) institution situated at the Royal Brisbane and Women’s Hospital (Herston, Brisbane). Its research funds are administered through The University of Queensland, School of Medicine.  The Director of QCGC Research is Professor Andreas Obermair who leads and develops the unit to produce meaningful research outcomes.

QCGC Research's mission is to develop the best standard of care for women experiencing gynaecological cancer. This may include finding causes for and preventing gynaecological cancer or finding better treatment options to cure women affected by gynaecological cancer.

We closely work with gynaecological oncology groups nationally (The Queensland University of Technology, The Queensland Institute of Medical Research, and the Australian and New Zealand Gynaecological Oncology Group (ANZGOG)) and internationally (MD Anderson Cancer Centre, Houston, TX; Johns Hopkins Medical Centres, Baltimore, PA; Memorial Sloan Kettering Cancer Centre, New York).

We focus on conducting surgical clinical trials in the field of gynaecological cancer but we also perform groundbreaking work outside the conventional clinical trials framework. We also teach and train new researchers (M.D. and Ph.D. programs) who will then take over as the research elite of tomorrow.

Our research is funded partly by competitive research grants (NHMRC project grants, smart state research grants, Cancer Australia) and by support from individual and corporate donors.